Company overview

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA and Philadelphia, PA and in England in London, Oxford and Cambridge, with manufacturing facilities in Ireland, England and Italy. We maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to patients with critical unmet needs. Please see our website at www.jazzpharma.com for more information. For information on recruitment, please visit https://careers.jazzpharma.com/. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.
Founded in 2003
Dublin 4, County Dublin, IRL
3.6K employees (220 in marketing)
56% recommend to a friend
44% positive business outlook

Salaries

Typical salary range

$160,000 – $240,000

/ yr

Help build salary transparency at Jazz Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

33 open now

Headcount trend

Company growth over the last 12 months

Headcount +2.2% year over year

Funding

Total funding

$2.8B

Last raise

$850M

Post IPO Debt, 2 years ago

Funding history

Sep 2024

Post IPO Debt Jazz Pharmaceuticals · $850M

Apr 2021

Post IPO Debt Jazz Pharmaceuticals · $1.5B

Dec 2009

Post IPO Debt Jazz Pharmaceuticals · $120M

Jul 2009

Post IPO Equity Jazz Pharmaceuticals · $7M

May 2008

Post IPO Equity Jazz Pharmaceuticals · $75M

Mar 2004

Series B Jazz Pharmaceuticals · $250M

Audience

Monthly website visitors
90K
Month over month+6.6%
Quarter over quarter+13.4%
Top sourceSearch (40.5%)
Ad budget per month$0.0
Average search rank49.4
Traffic source mix
Search
40.5%
Direct
40.2%
Referral
10.9%
Social
7.4%
Paid referral
0.8%

LinkedIn followers

Follower count and growth

Total followers

237.2K

12-mo growth

+30.5%

Monthly growth

+2.4%

News

Links